Current status and key Role of Neutraceuticals in diabetes: A comprehensive review

Authors

  • Pratibha Department of Pharmaceutics, Shri Ram College of Pharmacy, Muzaffarnagar, India-251001,
  • Avnica Tyagi Department of Pharmaceutics, School of Pharmaceutical sciences, Lovely Professional University, Phaghwara, Punjab, India
  • Km. Reenu Northan institute of pharmacy and Research, 12th Mile Stone, Baldeobas, Alwar - Bhiwadi Rd, Alwar, Rajasthan 301028
  • Dr. Girendra Kumar Gautam Department of Pharmaceutics, Shri Ram College of Pharmacy, Muzaffarnagar, India-251001,

DOI:

https://doi.org/10.22270/ajprd.v14i4.1857

Abstract

Hyperglycemia is a hallmark of diabetes mellitus, a long-term metabolic disease brought on by deficiencies in insulin activity, production, or both. Diabetes is becoming more commonplace worldwide, which has led to a lot of research into different treatment approaches. Among these, nutraceuticals have garnered significant attention due to their potential benefits in managing diabetes. Nutraceuticals are health-promoting food-derived products that present a possible alternative to traditional diabetic therapies.The role of different nutraceuticals, such as vitamins, minerals, antioxidants, and plant-based substances, in the treatment of diabetes mellitus is examined in this review. Important nutraceuticals with anti-diabetic qualities include omega-3 fatty acids, chromium, alpha-lipoic acid, and polyphenols from plants including bitter melon, green tea, and cinnamon. Along with clinical data demonstrating their effectiveness, the processes by which these substances affect insulin sensitivity, glycemic management, and diabetic complications are examined. Although nutraceuticals offer a strong supplement to diabetes treatment, further study is required to completely understand their mechanisms, ideal dosages, and long-term safety. The potential of nutraceuticals as a component of an integrated approach to diabetes management is highlighted in this review, which also emphasizes the necessity of individualized treatment plans based on patient profiles.

 

Downloads

Download data is not yet available.

Author Biography

Pratibha, Department of Pharmaceutics, Shri Ram College of Pharmacy, Muzaffarnagar, India-251001,

  •  

References

Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose (Santaguida PL, Balion C, Hunt D, et al.). Evid Rep Technol Assess. 128:1–11, 2005.

Dietary antioxidant intake and type 2 diabetes risk: Montonen J, Knekt P, Järvinen R, et al. Diabetes Care, 27(2), 362-366, 2004.

Bahadoran Z, Golzarand M, Mirmiran P, et al. Dietary total antioxidant capacity and the incidence of metabolic syndrome and its components following a 3-year follow up in adults: Tehran lipid and glucose study. Nutr Metab. 2012;9(1):70.

Mirmiran P, Bahadoran Z, Golzarand M, et al. Association between dietary phytochemical index and 3-year changes in weight, waist circumference and body adiposity index in adults: Tehran lipid and glucose study. Nutr Metab. 2012;9(1):108.

Zeisel SH. Science, 1999, 285(5435):1853–1855, Regulation of "Nutraceuticals."

Whitman M. Understanding the perceived need for complementary and alternative nutraceuticals: lifestyle issues. Clin J Oncol Nurs. 5(5):190–194, 2001.

Coccinia indica leaves' impact on antioxidant status in streptozotocin-induced diabetic rats, Venkateswaran S, Pari L. J. Ethnopharmacol. 2003; 84(2-3):163–168.

Suba V, Murugesan T, Arunachalam G, et al. Barleria lupulina extract's ability to prevent diabetes in rats. Fitoterapy. 75(1):1-4, 2004.

Hathcock J. Dietary supplements: Their usage and regulation. J Nutr. 131(3s):1114S-1117S, 2001.

Eperjesi F, Bartlett HE. A systematic review of nutritional supplements for type 2 diabetes. 2008; Ophthalmic Physiol Opt. 28(6):503–523.

Published

2026-08-15

How to Cite

Pratibha, Avnica Tyagi, Km. Reenu, & Dr. Girendra Kumar Gautam. (2026). Current status and key Role of Neutraceuticals in diabetes: A comprehensive review . Asian Journal of Pharmaceutical Research and Development, 14(4), 110–115. https://doi.org/10.22270/ajprd.v14i4.1857